首页> 美国卫生研究院文献>Medical Principles and Practice >Successful Therapy of Severe Pseudomembranous Clostridium difficile Colitis Using a Combination of Fecal Microbiota Therapy and Fidaxomicin

【2h】

Successful Therapy of Severe Pseudomembranous Clostridium difficile Colitis Using a Combination of Fecal Microbiota Therapy and Fidaxomicin

机译：粪便微生物群疗法和非达索霉素的联合成功治疗重度伪膜性艰难梭菌结肠炎

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectiveThe aim of this work was to describe the use of a combination of fidaxomicin and fecal microbiota therapy (FMT) in Clostridium difficile infection (CDI).

机译：目的这项工作的目的是描述非达索霉素和粪便微生物群疗法（FMT）联合用于艰难梭菌感染（CDI）的方法。

著录项

期刊名称 Medical Principles and Practice
作者
Peter C. Konturek; Drilon Haziri; Harry Helfritzsch; Thomas Hess; Igor A. Harsch;
展开▼
作者单位

展开▼
年(卷),期 2017(26),2
年度 2017
页码 182–184
总页数 3
原文格式 PDF
正文语种
中图分类基础医学;
关键词

相似文献

外文文献
中文文献
专利

1. Successful Therapy of Severe Pseudomembranous Clostridium difficile Colitis Using a Combination of Fecal Microbiota Therapy and Fidaxomicin [J] . Konturek P.C., Haziri D., Helfritzsch H., Medical principles and practice: international journal of the Kuwait University, Health Science Centre . 2017,第2期

机译：粪便微生物群疗法和非达索霉素联合成功治疗重度伪膜性艰难梭菌结肠炎
2. IVIG – A cure to severe refractory NAP-1 Clostridium difficile colitis? A case of successful treatment of severe infection, which failed standard therapy including fecal microbiota transplants and fidaxomicin [J] . Kelley Coffman, Xian Jie Cindy Chen, Charles Okamura, ID Cases . 2017,第2期

机译：IVIG –可以治愈重度难治性NAP-1 艰难梭菌结肠炎吗？成功治疗严重感染的病例，但未通过标准治疗，包括粪便微生物菌群移植和非达索霉素
3. IVIG – A cure to severe refractory NAP-1 Clostridium difficile colitis? A case of successful treatment of severe infection, which failed standard therapy including fecal microbiota transplants and fidaxomicin [J] . Kelley Coffman, Xian Jie Cindy Chen, Charles Okamura, ID Cases . 2017,第1期

机译：IVIG –可以治愈重度难治性NAP-1 艰难梭菌结肠炎吗？成功治疗严重感染的病例，但未通过标准治疗，包括粪便微生物菌群移植和非达索霉素
4. Algorithm-based Antimicrobial Therapy in Diarrheic Calves: Impact on Antimicrobial Usage, Health and Fecal Microbiota [C] . Conference of the American College of Veterinary Internal Medicine (ACVIM) . 2017

机译：腹泻小牛中基于算法的抗微生物治疗：对抗菌用途，健康和粪便微生物的影响
5. The Efficacy of Fecal Microbiota Transplantation in Elderly Patients with Clostridium Difficile Infection [D] . Lee, Dayeun 2019

机译：粪便微生物群移植在老年腹菌感染患者中的疗效
6. IVIG – A cure to severe refractory NAP-1 Clostridium difficile colitis? A case of successful treatment of severe infection which failed standard therapy including fecal microbiota transplants and fidaxomicin [O] . Kelley Coffman, Xian Jie Cindy Chen, Charles Okamura, 2017

机译：IVIG –可以治愈重度难治性NAP-1艰难梭菌结肠炎吗？成功治疗严重感染的病例但标准治疗失败包括粪便菌群移植和非达索霉素
7. IVIG – A cure to severe refractory NAP-1 Clostridium difficile colitis? A case of successful treatment of severe infection, which failed standard therapy including fecal microbiota transplants and fidaxomicin [O] . Kelley Coffman, Xian Jie Cindy Chen, Charles Okamura, 2017

机译：IVIG - 治疗严重难治性Nap-1艰难梭菌结肠炎？成功治疗严重感染的病例，其标准治疗失败，包括粪便微生物群移植和fidaxomicin
8. Guidance for Industry: Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium Difficile Infection Not Responsive to Standard Therapies. [R] . 2013

机译：行业指南：关于使用粪便微生物群移植治疗艰难梭菌感染的研究新药要求的执行政策不符合标准疗法。

Successful Therapy of Severe Pseudomembranous Clostridium difficile Colitis Using a Combination of Fecal Microbiota Therapy and Fidaxomicin

摘要

著录项

相似文献

相关主题

期刊订阅